Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Return on Assets: 2014-2018

Historic Return on Assets for Armata Pharmaceuticals (ARMP) over the last 4 years, with Sep 2018 value amounting to -1.39%.

  • Armata Pharmaceuticals' Return on Assets fell 19.00% to -1.39% in Q3 2018 from the same period last year, while for Sep 2018 it was -1.39%, marking a year-over-year decrease of 19.00%. This contributed to the annual value of -0.88% for FY2017, which is 12.00% down from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Return on Assets of -1.39% as of Q3 2018, which was down 13.46% from -1.23% recorded in Q2 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Return on Assets peaked at -0.29% during Q3 2015, and registered a low of -1.39% during Q3 2018.
  • In the last 3 years, Armata Pharmaceuticals' Return on Assets had a median value of -1.04% in 2016 and averaged -0.93%.
  • Its Return on Assets has fluctuated over the past 5 years, first spiked by 44bps in 2015, then tumbled by 85bps in 2017.
  • Armata Pharmaceuticals' Return on Assets (Quarterly) stood at -0.76% in 2014, then surged by 44bps to -0.32% in 2015, then plummeted by 59bps to -0.91% in 2016, then climbed by 13bps to -0.78% in 2017, then dropped by 19bps to -1.39% in 2018.
  • Its Return on Assets stands at -1.39% for Q3 2018, versus -1.23% for Q2 2018 and -0.78% for Q4 2017.